National Drug Schedules

NOTE - Effective December 19, 2013, Schedule F to the Food and Drug Regulationswas repealed and replaced by a list of prescription drugs, called the Prescription Drug List. Therefore, all entries in the National Drug Schedules (NDS) whose footnote indicates that they appear in Schedule F (F1/F2) should now be considered part of the Prescription Drug List (PDL).

Entries whose footnote indicates that they are "Schedule F Recommended" (FR) should now be considered recommended for addition to the PDL. Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS.

For more information on the Prescription Drug List, please consult the Health Canada website.

Drug Product Database
Licensed Natural Health Products Database

Print Friendly Export to CSV

Drug Name	Comment	Schedule	Date
Famciclovir or its salts^PDL		I	DEC / 13
Famotidine and its salts.	For human use - when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 600 mg of famotidine.	III	MAY / 08
Famotidine and its salts..	For human use - when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 600 mg of famotidine.	U	FEB / 07
Famotidine or its salts^PDL	For human use - except when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn.	I	DEC / 13
Famotidine or its salts^PDL	For veterinary use.	I	DEC / 13
Fampridine or its salts or derivatives^PDL		I	DEC / 13
Febuxostat or its salts or derivatives^PDL		I	DEC / 13
Felodipine or its salts^PDL		I	DEC / 13
Fenetylline and any salt thereof^C5		I	JAN / 03
Fenfluramine or its salts^PDL	Including but not limited to dexfenfluramine.	I	DEC / 13
Fenofibrate^PDL		I	DEC / 13
Fenoprofen or its salts^PDL		I	DEC / 13
Fenoterol or its salts^PDL		I	DEC / 13
Fenproporex^TS		I	JUN / 02
Fentanyl^N		I	JUN / 02
Fesoterodine or its salts^PDL	Including but not limited to fesoterodine fumarate.	I	DEC / 13
Fexofenadine hydrochloride	in products marketed for adult use (12 years and older)	U	APR / 07
Fexofenadine hydrochloride.	in products marketed for paediatric use (under 12 years of age)	III	APR / 07
Fibrin		II	SEP / 98
Fibrinolysin		II	SEP / 98
Fidaxomicin or its derivatives^PDL		I	DEC / 13
Filgrastim^PDL		I	DEC / 13
Finafloxacin or its salts or its derivatives^PDL		I	AUG / 16
Finasteride^PDL		I	DEC / 13
Fingolimod or its salts or derivatives^PDL	Including but not limited to fingolimod hydrochloride.	I	DEC / 13
Firocoxib^PDL		I	DEC / 13
Flavoxate or its salts^PDL		I	DEC / 13
Flecainide or its salts^PDL		I	DEC / 13
Fleroxacin or its salts or derivatives^PDL		I	DEC / 13
Flibanserin or its salts^PDL		I	MAY / 18
Floctafenine^PDL		I	DEC / 13
Florfenicol or its derivatives^PDL		I	DEC / 13
Fluconazole^PDL	For veterinary use.	I	DEC / 13
Fluconazole^PDL	For human use - except when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis.	I	DEC / 13
Fluconazole	For human use - when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis, in package sizes containing no more than 150 mg of fluconazole.	III	MAR / 10
Flucytosine^PDL		I	DEC / 13
Fludarabine or its salts or derivatives^PDL		I	DEC / 13
Fludiazepam^TS		I	JUN / 02
Flumazenil		I	SEP / 98
Flunarizine or its salts^PDL		I	DEC / 13
Flunitrazepam^TS		I	JUN / 02
Flunixin or its salts or derivatives^PDL	Including but not limited to flunixin meglumine.	I	DEC / 13
Fluoride or its salts (see sodium fluoride)^PDL	For human use - in solid oral dosage forms containing more than 1 mg of fluoride ion.	I	DEC / 13
Fluorouracil or its derivatives^PDL	Including but not limited to capecitabine, tegafur.	I	DEC / 13
Fluoxetine or its salts^PDL		I	DEC / 13
Fluoxymesterone^C3		I	JUN / 02
Flupentixol or its salts or derivatives^PDL	Including but not limited to flupentixol decanoate.	I	DEC / 13
Fluphenazine or its salts^PDL		I	DEC / 13
Fluralaner^PDL		I	JUN / 14
Flurazepam and its salts^TS		I	SEP / 98
Flurbiprofen or its salts^PDL		I	DEC / 13
Fluspirilene^PDL		I	DEC / 13
Flutamide^PDL		I	DEC / 13
Fluticasone propionate	When sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing no more than 360 metered sprays.	III	JAN / 20
Fluticasone propionate	When sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing more than 360 metered sprays.	II	JAN / 20
Fluvastatin or its salts or derivatives^PDL		I	DEC / 13
Fluvoxamine or its salts^PDL		I	DEC / 13
Folic acid^PDL	For human use - in oral dosage form containing more than 1.0 milligram of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 milligram of folic acid.	I	DEC / 13
Follicle stimulating hormone^PDL	including but not limited to: follitropin alpha, follitropin beta, follitropin delta	I	DEC / 13
Fomepizole or its salts^PDL		I	DEC / 13
Fondaparinux sodium^PDL		I	DEC / 13
Formebolone^C3		I	SEP / 98
Formestane or its derivatives^PDL		I	DEC / 13
Formoterol or its salts^PDL		I	DEC / 13
Foscarnet sodium^PDL		I	DEC / 13
Fosfomycin or its salts^PDL		I	DEC / 13
Fosinopril or its salts^PDL		I	DEC / 13
Fosphenytoin or its salts^PDL		I	DEC / 13
Fractar		III	SEP / 98
Framycetin or its salts or derivatives^PDL	For human use.	I	DEC / 13
Fremanezumab^PDL		I	JUL / 20
Frovatriptan or its salts^PDL		I	DEC / 13
Fulvestrant^PDL		I	DEC / 13
Furaltadone or its salts^PDL	For human use.	I	DEC / 13
Furazabol^C3		I	SEP / 98
Furazolidone or its salts^PDL	For human use.	I	DEC / 13
Furethidine^N		I	JUN / 02
Furosemide^PDL	For human use.	I	DEC / 13
Fusidic acid or its salts^PDL		I	DEC / 13

79 result(s)

Print Friendly Export to CSV

Footnotes

C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
C4: drug is in the Controlled Drugs and Substances Act
C5: drug is in the Regulations Under CDSA
CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR: drug has not been reviewed by NDSAC
PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
U: drug has been reviewed by NDSAC and is unscheduled

National Drug Schedules

Search: National Drug Schedules

79 result(s)

Footnotes